Workshop on intussusception in African countries - Meeting report

Vaccine

Volumn 30, Issue SUPPL. 1, 2012, Pages

  Steele, A Duncan ^a,e   Patel, Manish ^b   Cunliffe, Nigel A ^c   Bresee, Joe S ^b   Borgstein, Eric ^d   Parashar, Umesh D ^b  

^a PATH   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d UNIVERSITY OF MALAWI   (Malawi)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Africa; Intussusception; Rotavirus; Vaccines

Indexed keywords

ENEMA; ROTAVIRUS VACCINE;

AFRICA; AGE; CONFERENCE PAPER; DRUG SAFETY; FATALITY; HUMAN; INTUSSUSCEPTION; MALAWI; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SEASONAL VARIATION; ULTRASOUND; VACCINATION; WORLD HEALTH ORGANIZATION;

AFRICA; CHILD, PRESCHOOL; HUMANS; INFANT; INFANT, NEWBORN; INTUSSUSCEPTION; PREVALENCE; PRODUCT SURVEILLANCE, POSTMARKETING; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES;

EID: 84859999641     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.10.004     Document Type: Conference Paper

References (23)

1. Tate J.E., Burton A.H., Boschi-Pinto C., Steele A.D., Duque J., Parashar U.D., et al. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis 2012, 12(2):131-141.
2. WHO Meeting of the Strategic Advisory Group of Experts on immunization, October 2009, conclusions and recommendations. Wkly Epidemiol Rec 2009, 84(December (50)):518.
3. Patel M.M., Haber P., Baggs J., Zuber P., Bines J.E., Parashar U.D. Intussusception and rotavirus vaccination: a review of the available evidence. Expert Rev Vaccines 2009, 8(November (11)):1555-1564.
4. Murphy T.V., Gargiullo P.M., Massoudi M.S., Nelson D.B., Jumaan A.O., Okoro C.A., et al. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med 2001, 344(February (8)):564-572.
5. Vesikari T., Matson D.O., Dennehy P., Van Damme P., Santosham M., Rodriguez Z., et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006, 354(January (1)):23-33.
6. Ruiz-Palacios G.M., Perez-Schael I., Velazquez F.R., Abate H., Breuer T., Clemens S.C., et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006, 354(January (1)):11-22.
7. WHO Rotavirus vaccines. Wkly Epidemiol Rec 2007, 82(August (32)):285-295.
8. WHO Meeting of the Global Advisory Committee on Vaccine Safety, December 2010. Wkly Epidemiol Rec 2011, 86(January (5)):38-43.
9. Cortese M. Estimates of benefits and potential risks of rotavirus vaccination in the U.S. Presented at the Advisory Committee on Immunization Practices Meeting; Atlanta, GA, USA; October 2010.
10. Buttery J.P., Danchin M.H., Lee K.J., Carlin J.B., McIntyre P.B., Elliott E.J., et al. Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia. Vaccine 2011, 29(16):3061-3066.
11. Richardson V., Hernandez-Pichardo J., Quintanar-Solares M., Esparza-Aguilar M., Johnson B., Gomez-Altamirano C.M., et al. Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N Engl J Med 2010, 362(January (4)):299-305.
12. Quintanar-Solares M., Yen C.Y., Esparza-Aguilar M., Richardson V., Parashar U., Patel M.M. Impact of rotavirus vaccination on diarrhea-related hospitalizations among children <5 Years of Age in Mexico. Pediatr Infect Dis 2011, 30:S11-S15.
13. WHO. Acute intussusception in infants and children. Incidence, clinical presentation and management: a global perspective. Geneva: World Health Organization. Document WHO/V & B/02.19. 2002, 1-98.
14. Bines J.E., Patel M., Parashar U. Assessment of postlicensure safety of rotavirus vaccines, with emphasis on intussusception. J Infect Dis 2009, 200(November (Suppl. 1)):S282-S290.
15. Tate J.E., Simonsen L., Viboud C., Steiner C., Patel M.M., Curns A.T., et al. Trends in intussusception hospitalizations among US infants, 1993-2004: implications for monitoring the safety of the new rotavirus vaccination program. Pediatrics 2008, 121(May (5)):e1125-e1132.
16. WHO Rotavirus vaccines: an update. Wkly Epidemiol Rec 2009, 84(December (50)):533-540.
17. Patel M.M., Clark A.D., Glass R.I., Greenberg H., Tate J., Santosham M., et al. Broadening the age restriction for initiating rotavirus vaccination in regions with high rotavirus mortality: benefits of mortality reduction versus risk of fatal intussusception. Vaccine 2009, 27(May (22)):2916-2922.
18. Clark A., Sanderson C. Timing of children's vaccinations in 45 low-income and middle-income countries: an analysis of survey data. Lancet 2009, 373(May (9674)):1543-1549.
19. Armah G.E., Pager C.T., Asmah R.H., Anto R., Ouduro R., Binka F.N., et al. Prevalence of unusual human rotavirus strains in Ghanaian children. J Med Virol 2001, 63:67-71.
20. Steele A.D., Peenze I., de Beer M.C., Pager C.T., Yeats J., Potgieter N., et al. Anticipating rotavirus vaccines: epidemiology and surveillance of rotavirus in South Africa. Vaccine 2003, 21:354-360.
21. Stein M., Alton D.J., Daneman A. Pneumatic reduction of intussusception: 5-year experience. Radiology 1992, 183(June (3)):681-684.
22. Bines J.E., Kohl K.S., Forster J., Zanardi L.R., Davis R.L., Hansen J., et al. Acute intussusception in infants and children as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation. Vaccine 2004, 22(January (5-6)):569-574.
23. Pruksananonda P. Intussusception in a private tertiary-care hospital, Bangkok, Thailand: a case series. Southeast Asian J Trop Med Public Health 2007, 38(March (2)):339-342.